SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-13-004233
Filing Date
2013-10-29
Accepted
2013-10-29 17:02:47
Documents
2
Period of Report
2013-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K FILING DOCUMENT document.htm 6-K 3803
2 PRESS RELEASE newsrelease.htm EX-99 5812
  Complete submission text file 0001171843-13-004233.txt   10621
Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3
Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 131177023
SIC: 2834 Pharmaceutical Preparations